Airsonett is a research based medical technology company with a unique technology which leads the development of preventative and secondary preventative treatment of allergic asthma as well as management of airborne bacteria and virus contamination. Airsonett has an extensive patent portfolio and is investing heavily in clinical research and product development.

Protexo^® is a secondary preventative device which minimizes the exposure of allergen during night time. Protexo is recommended to patients with moderate to severe perennial allergic asthma (such as pet and mite allergies). Previous models of Protexo were marketed under the name Airsonett Airshower.

Opragon^® is a complete product line for reduction of airborne bacterial contamination for various hospital environments, primarily for infection sensitive surgery. Opragon was previously marketed under the name Airshower Polygon.